Insider Trading Alert - EMN, WLK And ACAS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 27, 2014, 119 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $99.26 to $40,800,000.00.

Highlighted Stocks Traded by Insiders:

Eastman Chemical Company (EMN) - FREE Research Report

Cox Mark K who is Senior Vice President at Eastman Chemical Company sold 2,100 shares at $84.52 on Feb. 27, 2014. Following this transaction, the Senior Vice President owned 1,959 shares meaning that the stake was reduced by 51.74% with the 2,100-share transaction.

The shares most recently traded at $87.34, up $2.82, or 3.23% since the insider transaction. Historical insider transactions for Eastman Chemical Company go as follows:

  • 24-Week # shares sold: 5,200

The average volume for Eastman Chemical Company has been 1.8 million shares per day over the past 30 days. Eastman Chemical Company has a market cap of $13.2 billion and is part of the basic materials sector and chemicals industry. Shares are up 7.57% year-to-date as of the close of trading on Thursday.

Eastman Chemical Company, a specialty chemical company, engages in the manufacture and sale of chemicals, plastics, and fibers in the United States and internationally. The stock currently has a dividend yield of 1.63%. The company has a P/E ratio of 17.9. Currently there are 11 analysts that rate Eastman Chemical Company a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EMN - FREE

TheStreet Quant Ratings rates Eastman Chemical Company as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, notable return on equity, attractive valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Eastman Chemical Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Westlake Chemical Corporation (WLK) - FREE Research Report

Mangieri George J who is VP & Chief Accounting Officer at Westlake Chemical Corporation sold 354 shares at $133.01 on Feb. 27, 2014. Following this transaction, the VP & Chief Accounting Officer owned 12,238 shares meaning that the stake was reduced by 2.81% with the 354-share transaction.

The shares most recently traded at $135.21, up $2.20, or 1.63% since the insider transaction. Historical insider transactions for Westlake Chemical Corporation go as follows:

  • 4-Week # shares sold: 2,534
  • 12-Week # shares sold: 2,534
  • 24-Week # shares sold: 2,534

The average volume for Westlake Chemical Corporation has been 372,200 shares per day over the past 30 days. Westlake Chemical Corporation has a market cap of $8.9 billion and is part of the basic materials sector and chemicals industry. Shares are up 8.37% year-to-date as of the close of trading on Thursday.

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and fabricated building products. It operates in two segments, Olefins and Vinyls. The stock currently has a dividend yield of 0.76%. The company has a P/E ratio of 14.6. Currently there are 3 analysts that rate Westlake Chemical Corporation a buy, 2 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WLK - FREE

TheStreet Quant Ratings rates Westlake Chemical Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Westlake Chemical Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

American Capital (ACAS) - FREE Research Report

Flax Samuel Allan who is EVP, GC and Secretary at American Capital sold 337 shares at $15.49 on Feb. 27, 2014. Following this transaction, the EVP, GC and Secretary owned 413,082 shares meaning that the stake was reduced by 0.08% with the 337-share transaction.

The shares most recently traded at $15.48, down $0.01, or 0.06% since the insider transaction. Historical insider transactions for American Capital go as follows:

  • 4-Week # shares sold: 192,113
  • 12-Week # shares bought: 15,000
  • 12-Week # shares sold: 218,383
  • 24-Week # shares bought: 15,000
  • 24-Week # shares sold: 304,592

The average volume for American Capital has been 2.7 million shares per day over the past 30 days. American Capital has a market cap of $4.4 billion and is part of the financial sector and financial services industry. Shares are down 0.96% year-to-date as of the close of trading on Thursday.

American Capital, Ltd. is a private equity and venture capital firm specializing in management and employee buyouts, leveraged finance, mezzanine, acquisition, recapitalization, middle market, and growth capital investments. The company has a P/E ratio of 30.4. Currently there are 2 analysts that rate American Capital a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACAS - FREE

TheStreet Quant Ratings rates American Capital as a hold. The company's strengths can be seen in multiple areas, such as its expanding profit margins and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full American Capital Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)